Armored modified vaccinia Ankara in cancer immunotherapy
Author:
Publisher
Elsevier
Reference230 articles.
1. Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer;Albers;Scientific Reports,2018
2. Modified vaccinia virus Ankara preferentially targets antigen presenting cells in vitro, ex vivo and in vivo;Altenburg;Scientific Reports,2017
3. Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma;Alva;Cancer Immunology, Immunotherapy: CII,2016
4. Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): A phase 2 trial;Amato;Journal of Immunotherapy (Hagerstown, Md.: 1997),2008
5. Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: A phase II trial;Amato;Clinical Cancer Research: An Official Journal of the American Association for Cancer Research,2008
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3